Home - Products - Membrane Transporter/Ion Channel - Beta Amyloid - BSBM7

BSBM7

CAS No. 6968-11-2

BSBM7( —— )

Catalog No. M22384 CAS No. 6968-11-2

BSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	29	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	26	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BSBM7
Note

Research use only, not for human use.
Brief Description

BSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
Description

BSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
In Vitro

Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
In Vivo

——
Synonyms

——
Pathway

Membrane Transporter/Ion Channel
Target

Beta Amyloid
Recptor

Aβ
Research Area

——
Indication

——

Chemical Information

CAS Number

6968-11-2
Formula Weight

508.56
Molecular Formula

C22H24N2O8S2
Purity

>98% (HPLC)
Solubility

——
SMILES

OC(=O)[C@H](CSSC[C@H](NC(=O)OCc1ccccc1)C(O)=O)NC(=O)OCc1ccccc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

MK-3328

MK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease.
β-Amyloid 1-20

This synthetic peptide consists of amino acids 1 to 20 of beta amyloid protein.
PPI-1019

PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).

Sign In Join Free